ProfileGDS4132 / 225950_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 86% 77% 85% 74% 77% 82% 82% 90% 85% 81% 77% 80% 89% 84% 73% 84% 87% 85% 84% 76% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101332.5486
GSM201543Muscle PCOS pioglitazone 121239.33477
GSM201544Muscle PCOS pioglitazone 161345.42385
GSM201545Muscle PCOS pioglitazone 201250.11674
GSM201829Muscle PCOS pioglitazone 231258.89377
GSM201830Muscle PCOS pioglitazon 251292.85882
GSM201831Muscle PCOS pioglitazone 271302.12582
GSM201832Muscle PCOS pioglitazone 31441.16590
GSM201833Muscle PCOS pioglitazone 41319.5885
GSM201834Muscle PCOS pioglitazone 81292.26581
GSM201835Muscle PCOS after pioglitazone 102250.01577
GSM201836Muscle PCOS after pioglitazone 122273.96680
GSM201837Muscle PCOS after pioglitazone 162413.04589
GSM201838Muscle PCOS after pioglitazone 202338.27484
GSM201839Muscle PCOS after pioglitazone 232226.09973
GSM201840Muscle PCOS after pioglitazone 252350.81684
GSM201841Muscle PCOS after pioglitazone 272362.10487
GSM201842Muscle PCOS after pioglitazone 32310.56885
GSM201843Muscle PCOS after pioglitazone 42322.27684
GSM201844Muscle PCOS after pioglitazone 82254.93476